Patent · US Active

Compounds, compositions and methods

US7538223B2 · kind B2 · utility

17Cited by
14References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2006
Grant dateMay 26, 2009
Priority date
Expiry dateOct 21, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.